Addus HomeCare Co. (NASDAQ:ADUS – Get Rating) Executive Vice President Darby Anderson sold 7,500 shares of the company in a trade that took place on Tuesday, October 4. The stock was sold at an average price of $100.00, for a total transaction of $750,000.00. Following completion of the transaction, the executive vice president now directly owns 35,090 shares of the company, valued at approximately $3,509,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Addus HomeCare Price Performance

Shares of Addus HomeCare rose $0.46 on Thursday, hitting $97.89. 48,127 shares of the company were traded, against an average volume of 81,587. The stock has a market capitalization of $1.57 billion, a P/E ratio of 35.47, a price/earnings ratio of growth of 2.65 and a beta of 0.77. The company has a debt ratio of 0.33, a quick ratio of 2.00 and a current ratio of 2.00. Addus HomeCare Co. has a 52-week low of $68.57 and a 52-week high of $108.11. The company has a 50-day simple moving average of $92.98 and a 200-day simple moving average of $87.81.

Addus HomeCare (NASDAQ:ADUS – Get Rating) last released quarterly earnings data on Monday, August 1. The company reported earnings per share (EPS) of $0.91 for the quarter, missing the consensus estimate of $0.92 per ($0.01). The company posted revenue of $236.94 million for the quarter, versus a consensus estimate of $238.40 million. Addus HomeCare had a net margin of 4.90% and a return on equity of 8.63%. The company’s quarterly revenue increased 8.7% year over year. In the same quarter of the previous year, the company achieved EPS of $0.78. Research analysts expect Addus HomeCare Co. to post earnings per share of 3.13 for the current fiscal year.

Analysts set new price targets

ADUS has been the subject of several analyst reports. Oppenheimer lowered his price target on Addus HomeCare stock from $135.00 to $130.00 and set an “outperform” rating on the stock in a Wednesday, Aug. 3 report. Stifel Nicolaus launched a hedge on Addus HomeCare shares in a Tuesday, June 28 report. They have set a “buy” rating and a price target of $101.00 on the stock. downgraded shares of Addus HomeCare from a “strong buy” rating to a “buy” rating in a Saturday, August 20 report. Stephens lowered his price target on Addus HomeCare shares from $110.00 to $101.00 and set an “overweight” rating on the stock in a Tuesday, June 21 report. Finally, Royal Bank of Canada lowered its price target on Addus HomeCare shares from $111.00 to $110.00 and set an “outperform” rating on the stock in a Wednesday, August 3 report. . Six analysts rated the stock with a buy rating. According to data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $110.40.

Institutional investors weigh in on Addus HomeCare

Several large investors have recently bought and sold shares of ADUS. Okabena Investment Services Inc. purchased a new stake in Addus HomeCare in the fourth quarter for $31,000. Assetmark Inc. increased its position in Addus HomeCare by 110.1% in the second quarter. Assetmark Inc. now owns 374 shares of the company worth $31,000 after purchasing an additional 196 shares in the last quarter. Point72 Hong Kong Ltd bought a new stake in Addus HomeCare in the second quarter worth $41,000. Financial Management Professionals Inc. bought a new stake in Addus HomeCare in the first quarter for $72,000. Finally, Heritage Wealth Management LLC purchased a new stake in Addus HomeCare in the second quarter at a value of $76,000. Institutional investors hold 95.03% of the company’s shares.

Addus HomeCare Company Profile

(Get a rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to the elderly, chronically ill, disabled, and those at risk of hospitalization or institutionalization in the United States. It operates through three segments: personal care, palliative care and home care.

Featured articles

Insider buying and selling by quarter for Addus HomeCare (NASDAQ:ADUS)

This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider Addus HomeCare, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Addus HomeCare didn’t make the list.

While Addus HomeCare currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here